These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 38852312)
1. Novel antibody-antibiotic conjugate using KRM-1657 as payload eliminates intracellular MRSA in vitro and in vivo. Fan S; Bai Y; Li Q; Liu L; Wang Y; Xie F; Dong Y; Wang Z; Lv K; Zhu H; Bi H; Zhou X Bioorg Chem; 2024 Sep; 150():107532. PubMed ID: 38852312 [TBL] [Abstract][Full Text] [Related]
2. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus. Lehar SM; Pillow T; Xu M; Staben L; Kajihara KK; Vandlen R; DePalatis L; Raab H; Hazenbos WL; Morisaki JH; Kim J; Park S; Darwish M; Lee BC; Hernandez H; Loyet KM; Lupardus P; Fong R; Yan D; Chalouni C; Luis E; Khalfin Y; Plise E; Cheong J; Lyssikatos JP; Strandh M; Koefoed K; Andersen PS; Flygare JA; Wah Tan M; Brown EJ; Mariathasan S Nature; 2015 Nov; 527(7578):323-8. PubMed ID: 26536114 [TBL] [Abstract][Full Text] [Related]
3. Antibody-antibiotic conjugate targeted therapy for orthopedic implant-associated intracellular S. aureus infections. Qin L; Hu N; Zhang Y; Yang J; Zhao L; Zhang X; Yang Y; Zhang J; Zou Y; Wei K; Zhao C; Li Y; Zeng H; Huang W; Zou Q J Adv Res; 2024 Nov; 65():239-255. PubMed ID: 38048846 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections. Shahin IG; Abutaleb NS; Alhashimi M; Kassab AE; Mohamed KO; Taher AT; Seleem MN; Mayhoub AS Eur J Med Chem; 2020 Sep; 202():112497. PubMed ID: 32707373 [TBL] [Abstract][Full Text] [Related]
5. Quinolone derivatives and their activities against methicillin-resistant Staphylococcus aureus (MRSA). Gao C; Fan YL; Zhao F; Ren QC; Wu X; Chang L; Gao F Eur J Med Chem; 2018 Sep; 157():1081-1095. PubMed ID: 30179746 [TBL] [Abstract][Full Text] [Related]
6. Novel natural osthole-inspired amphiphiles as membrane targeting antibacterials against methicillin-resistant Staphylococcus aureus (MRSA). Yang R; Xue Z; Li X; Xu T; Zhong Y; Hu S; Qin S; Guo Y Eur J Med Chem; 2024 May; 271():116449. PubMed ID: 38691893 [TBL] [Abstract][Full Text] [Related]
7. Novel membrane-targeting isoxanthohumol-amine conjugates for combating methicillin-resistant Staphylococcus aureus (MRSA) infections. Yang R; Cheng W; Huang M; Xu T; Zhang M; Liu J; Qin S; Guo Y Eur J Med Chem; 2024 Mar; 268():116274. PubMed ID: 38408389 [TBL] [Abstract][Full Text] [Related]
8. Antibody-Antibiotic Conjugates: A Novel Therapeutic Platform against Bacterial Infections. Mariathasan S; Tan MW Trends Mol Med; 2017 Feb; 23(2):135-149. PubMed ID: 28126271 [TBL] [Abstract][Full Text] [Related]
9. Novel two-chain fatty acid-based lipids for development of vancomycin pH-responsive liposomes against Makhathini SS; Kalhapure RS; Jadhav M; Waddad AY; Gannimani R; Omolo CA; Rambharose S; Mocktar C; Govender T J Drug Target; 2019 Dec; 27(10):1094-1107. PubMed ID: 30901236 [TBL] [Abstract][Full Text] [Related]
10. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia. Schuch R; Lee HM; Schneider BC; Sauve KL; Law C; Khan BK; Rotolo JA; Horiuchi Y; Couto DE; Raz A; Fischetti VA; Huang DB; Nowinski RC; Wittekind M J Infect Dis; 2014 May; 209(9):1469-78. PubMed ID: 24286983 [TBL] [Abstract][Full Text] [Related]
12. Sustained activity of novel THIOMAB antibody-antibiotic conjugate against Staphylococcus aureus in a mouse model: Longitudinal pharmacodynamic assessment by bioluminescence imaging. Zhou C; Cai H; Baruch A; Lewin-Koh N; Yang M; Guo F; Xu D; Deng R; Hazenbos W; Kamath AV PLoS One; 2019; 14(10):e0224096. PubMed ID: 31661493 [TBL] [Abstract][Full Text] [Related]
13. Housefly Phormicin inhibits Staphylococcus aureus and MRSA by disrupting biofilm formation and altering gene expression in vitro and in vivo. Wang B; Yao Y; Wei P; Song C; Wan S; Yang S; Zhu GM; Liu HM Int J Biol Macromol; 2021 Jan; 167():1424-1434. PubMed ID: 33202277 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy with iron chelation and vancomycin in treating murine staphylococcemia. Luo G; Spellberg B; Gebremariam T; Lee H; Xiong YQ; French SW; Bayer A; Ibrahim AS Eur J Clin Microbiol Infect Dis; 2014 May; 33(5):845-51. PubMed ID: 24292099 [TBL] [Abstract][Full Text] [Related]
15. Structure optimizing of flavonoids against both MRSA and VRE. Wei MZ; Zhu YY; Zu WB; Wang H; Bai LY; Zhou ZS; Zhao YL; Wang ZJ; Luo XD Eur J Med Chem; 2024 May; 271():116401. PubMed ID: 38640870 [TBL] [Abstract][Full Text] [Related]
16. Comparison of In Vivo Transportability of Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents Into Intracellular and Extracellular Tissue Spaces in Rats. Kobuchi S; Kita Y; Hiramatsu Y; Sasaki K; Uno T; Ito Y; Sakaeda T J Pharm Sci; 2021 Feb; 110(2):898-904. PubMed ID: 33164810 [TBL] [Abstract][Full Text] [Related]
18. A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus aureus in Keratinocytes and Has Potential as a Treatment for Skin Infections in Mice. Wang Z; Kong L; Liu Y; Fu Q; Cui Z; Wang J; Ma J; Wang H; Yan Y; Sun J Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625989 [No Abstract] [Full Text] [Related]